|
⚲
|
| Keyboard |
| Waddill William D
✚
|
|
|---|---|
| CIK # | 0001553338 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001553338] | |
| 4 | [0001553338] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Waddill William D | |
| Protagonist Therapeutics Inc | |
| Annexon Inc | |
| Arrowhead Pharmaceuticals Inc | |
| Turnstone Biologics Corp | |
| Calithera Biosciences Inc | |
| OncoMed Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2026-02-06 | Option exercise | 20,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-02-06 | Option exercise | 20,000 | $8.31 | 166,200 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-02-06 | Sell | 20,000 | $83.68 | 1,673,600 |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 3,762 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-01-02 | Grant | 2,695 | $0.00 | |
|
Arrowhead Pharmaceuticals Inc ARWR
Common Stock
|
2025-12-19 | Sell | 5,451 | $68.01 | 370,723 |
|
Arrowhead Pharmaceuticals Inc ARWR
Common Stock
|
2025-12-19 | Sell | 2,416 | $66.66 | 161,051 |
|
Arrowhead Pharmaceuticals Inc ARWR
Common Stock
|
2025-12-19 | Sell | 500 | $68.53 | 34,265 |
|
Arrowhead Pharmaceuticals Inc ARWR
Common Stock
|
2025-12-16 | Grant | 7,819 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2025-10-10 | Option exercise | 12,000 | $6.98 | 83,760 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2025-10-10 | Sell | 8,000 | $87.81 | 702,480 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2025-10-10 | Sell | 4,000 | $69.25 | 277,000 |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2025-10-10 | Option exercise | 12,000 | $0.00 | |
|
Annexon Inc ANNX
Stock Option (Right to Buy) · derivative
|
2025-06-05 | Grant | 55,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2025-03-17 | Sell | 4,000 | $54.25 | 217,000 |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2025-01-02 | Grant | 6,584 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2025-01-02 | Grant | 5,130 | $0.00 | |
|
Arrowhead Pharmaceuticals Inc ARWR
Common Stock
|
2024-12-18 | Grant | 16,733 | $22.99 | 384,692 |
|
Arrowhead Pharmaceuticals Inc ARWR
Common Stock
|
2024-12-17 | Sell | 3,747 | $22.04 | 82,584 |
|
Arrowhead Pharmaceuticals Inc ARWR
Common Stock
|
2024-12-16 | Sell | 3,748 | $21.90 | 82,081 |
| showing 20 of 81 most recent transactions | |||||